- Report
- July 2024
- 141 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2025
- 151 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- October 2024
- 198 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 400 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2024
- 181 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2023
- 104 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- December 2023
- 185 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2023
- 179 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
The Polymer Excipients market is a subset of the Pharmaceutical Intermediates market, which encompasses the production of active pharmaceutical ingredients (APIs) and other substances used in the manufacture of pharmaceuticals. Polymer Excipients are polymers used as excipients in the formulation of pharmaceuticals, such as tablets, capsules, and suspensions. These excipients are used to improve the stability, solubility, and bioavailability of the active ingredients. They also help to control the release of the active ingredients, and can be used to modify the physical properties of the drug.
Polymer Excipients are used in a variety of pharmaceutical applications, including drug delivery, drug formulation, and drug manufacturing. They are also used in the production of medical devices, such as implants and catheters.
Some companies in the Polymer Excipients market include BASF, Dow Chemical, Evonik Industries, Lubrizol, and Merck KGaA. Show Less Read more
